299 related articles for article (PubMed ID: 22249590)
61. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test.
Crotta S; Segnan N; Paganin S; Dagnes B; Rosset R; Senore C
Clin Gastroenterol Hepatol; 2012 Jun; 10(6):633-8. PubMed ID: 22426085
[TBL] [Abstract][Full Text] [Related]
62. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.
Haug U; Hundt S; Brenner H
Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091
[TBL] [Abstract][Full Text] [Related]
63. Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohort.
Leen R; Seng-Lee C; Holleran G; O'Morain C; McNamara D
Eur J Gastroenterol Hepatol; 2014 May; 26(5):514-8. PubMed ID: 24699725
[TBL] [Abstract][Full Text] [Related]
64. [Results of a multicentric colorectal cancer screening program in Chile].
López-Kostner F; Zárate AJ; Ponce A; Kronberg U; Kawachi H; Okada T; Tsubaki M; Ito T; Nishikage T; Tanaka K; Kawano T; Eishi Y; Peñaloza P; Estela R; Karelovic S; Flores S
Rev Med Chil; 2018 Jun; 146(6):685-692. PubMed ID: 30148899
[TBL] [Abstract][Full Text] [Related]
65. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.
Quintero E; Castells A; Bujanda L; Cubiella J; Salas D; Lanas Á; Andreu M; Carballo F; Morillas JD; Hernández C; Jover R; Montalvo I; Arenas J; Laredo E; Hernández V; Iglesias F; Cid E; Zubizarreta R; Sala T; Ponce M; Andrés M; Teruel G; Peris A; Roncales MP; Polo-Tomás M; Bessa X; Ferrer-Armengou O; Grau J; Serradesanferm A; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; de la Vega-Prieto M; Reyes-Melian JM; Cacho G; Díaz-Tasende J; Herreros-de-Tejada A; Poves C; Santander C; González-Navarro A;
N Engl J Med; 2012 Feb; 366(8):697-706. PubMed ID: 22356323
[TBL] [Abstract][Full Text] [Related]
66. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
[TBL] [Abstract][Full Text] [Related]
67. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
[TBL] [Abstract][Full Text] [Related]
68. Impact of subsequent screening episodes on the positive predictive value for advanced neoplasia and on the distribution of anatomic subsites of colorectal cancer: A population-based study on behalf of the French colorectal cancer screening program.
Azimafoussé Assogba GF; Jezewski-Serra D; Lastier D; Quintin C; Denis B; Beltzer N; Duport N
Cancer Epidemiol; 2015 Dec; 39(6):964-71. PubMed ID: 26546750
[TBL] [Abstract][Full Text] [Related]
69. Initial results of the National Colorectal Cancer Screening Program in Lithuania.
Poskus T; Strupas K; Mikalauskas S; Bitinaitė D; Kavaliauskas A; Samalavicius NE; Saladzinskas Z
Eur J Cancer Prev; 2015 Mar; 24(2):76-80. PubMed ID: 25370682
[TBL] [Abstract][Full Text] [Related]
70. Colonoscopy requirements of population screening for colorectal cancer in New Zealand.
Green T; Richardson A; Parry S
N Z Med J; 2012 Jun; 125(1356):85-95. PubMed ID: 22729063
[TBL] [Abstract][Full Text] [Related]
71. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms.
Dancourt V; Lejeune C; Lepage C; Gailliard MC; Meny B; Faivre J
Eur J Cancer; 2008 Oct; 44(15):2254-8. PubMed ID: 18760592
[TBL] [Abstract][Full Text] [Related]
72. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening.
Raginel T; Puvinel J; Ferrand O; Bouvier V; Levillain R; Ruiz A; Lantieri O; Launoy G; Guittet L
Gastroenterology; 2013 May; 144(5):918-25. PubMed ID: 23376426
[TBL] [Abstract][Full Text] [Related]
73. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study.
Jensen CD; Corley DA; Quinn VP; Doubeni CA; Zauber AG; Lee JK; Zhao WK; Marks AR; Schottinger JE; Ghai NR; Lee AT; Contreras R; Klabunde CN; Quesenberry CP; Levin TR; Mysliwiec PA
Ann Intern Med; 2016 Apr; 164(7):456-63. PubMed ID: 26811150
[TBL] [Abstract][Full Text] [Related]
74. [Lesions detected in a colorectal cancer screening program in the Basque Country: first round (2009-2011)].
Portillo I; Idígoras I; Ojembarrena E; Arana E; Luis Hurtado J; Basurko R; Tapia M; Luz Peña M
Gastroenterol Hepatol; 2013 May; 36(5):301-8. PubMed ID: 23618538
[TBL] [Abstract][Full Text] [Related]
75. Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection.
Haug U; Knudsen AB; Lansdorp-Vogelaar I; Kuntz KM
Int J Cancer; 2015 Jun; 136(12):2864-74. PubMed ID: 25403937
[TBL] [Abstract][Full Text] [Related]
76. The calculation of targets for the cancer and adenoma detection rates for the NHS bowel screening programme.
Blanks RG; Moss SM
J Med Screen; 2012 Jun; 19(2):72-6. PubMed ID: 22569075
[TBL] [Abstract][Full Text] [Related]
77. Organized colorectal cancer screening in Serbia - the first round within 2013-2014.
Banković Lazarević D; Krivokapić Z; Barišić G; Jovanović V; Ilić D; Veljković M
Vojnosanit Pregl; 2016 Apr; 73(4):360-7. PubMed ID: 29309104
[TBL] [Abstract][Full Text] [Related]
78. Predictive Levels of CD24 in Peripheral Blood Leukocytes for the Early Detection of Colorectal Adenomas and Adenocarcinomas.
Kraus S; Shapira S; Kazanov D; Naumov I; Moshkowitz M; Santo E; Galazan L; Geva R; Shmueli E; Hallack A; Arber N
Dis Markers; 2015; 2015():916098. PubMed ID: 26078485
[TBL] [Abstract][Full Text] [Related]
79. Colorectal cancer in a second round after a negative faecal immunochemical test.
Bujanda L; Sarasqueta C; Castells A; Pellisé M; Cubiella J; Gil I; Cosme A; Arana-Arri E; Mar I; Idigoras I; Portillo I;
Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):813-8. PubMed ID: 25856688
[TBL] [Abstract][Full Text] [Related]
80. Fecal immunochemical test accuracy in familial risk colorectal cancer screening.
Castro I; Cubiella J; Rivera C; González-Mao C; Vega P; Soto S; Hernandez V; Iglesias F; Teresa Alves M; Bujanda L; Fernández-Seara J
Int J Cancer; 2014 Jan; 134(2):367-75. PubMed ID: 23818169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
